Lianghong I. Ying
Huai'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and safety of Suhuang Zhike capsule for cough variant asthma: a multicenter, single-arm, open-label phase IV real-world clinical trial.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: August 14, 2025
Knockdown of AMFR Alleviates Atrial Fibrosis in Atrial Fibrillation by Stabilizing SOD1 Protein Expression.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: July 22, 2025
Proteomics analysis of coronary atherosclerotic heart disease with different Traditional Chinese Medicine syndrome types before and after percutaneous coronary intervention.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: May 20, 2024
Single Bolus r-SAK Before Primary PCI for ST-Segment-Elevation Myocardial Infarction.
Journal: Circulation. Cardiovascular interventions
Published: January 23, 2024
Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: January 12, 2024
Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.
Journal: Clinical cardiology
Published: February 16, 2023
Inhibition of lncRNA NFIA-AS1 Alleviates Abnormal Proliferation and Inflammation of Vascular Smooth Muscle Cells in Atherosclerosis by Regulating miR-125a-3p/AKT1 Axis.
Journal: International journal of genomics
Published: August 29, 2022
Use of handheld electrocardiograph (SnapECG) for the remote monitoring of arrhythmias.
Journal: Digital health
Published: April 06, 2022
Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
Journal: British journal of haematology
Published: May 04, 2021
Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
Journal: Circulation. Cardiovascular interventions
Published: April 26, 2019
Vildagliptin Reduces Stenosis of Injured Carotid Artery in Diabetic Mouse Through Inhibiting Vascular Smooth Muscle Cell Proliferation via ER Stress/NF-κB Pathway.
Journal: Frontiers in pharmacology
Published: April 13, 2018
Impact of hepatitis B virus (HBV) infection on platelet response to clopidogrel in patients undergoing coronary stent implantation.
Journal: Thrombosis research
Published: February 14, 2018
Last Updated: 09/26/2026